Microvascular Angina clinical trials

The registry lists 111 studies for Microvascular Angina across more than 10 countries. 39 are recruiting or about to start. 71 of them are mainly about Microvascular Angina (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Microvascular Angina studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 33
Recruiting: 27
Status unknown: 16
Active, not recruiting: 14
Not yet recruiting: 7
Terminated: 7

Phase

Phase 4: 17
Phase 2: 7
Phase 3: 5
Phase 1: 2
Early Phase 1: 1

Where

United States: 22
United Kingdom: 18
China: 15
Germany: 7
Netherlands: 7
Denmark: 6

Who runs them

Qilu Hospital of Shandong University (6) · University Hospital, Grenoble (4) · NHS National Waiting Times Centre Board (4) · Bispebjerg Hospital (3) · Samsung Medical Center (3) · Johannes Gutenberg University Mainz (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · Queen Mary University of London (2)

What is being tested here

Drugs under test in Microvascular Angina studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Nebivolol	1	1	2
Cisplatin	1	0	1
Bexagliflozin	1	0	1
Amlodipine	1	1	1
Diltiazem	0	1	2
Ranolazine	0	0	2
Bivalirudin	0	0	1
Adenosine	0	0	1
Heparin	0	0	1
Prednisolone	0	1	1

Drug classes tested here Calcium channel blockers 1 open · Beta blockers 1 open

Coming up

4phase 3 studies under way

13studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Dec 2026Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries · Phase 3 · Stanford University
Dec 2026Self-Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD) (SERRA-I Study) · VahatiCor, Inc.
Dec 2026The FLARE (Flurpiridaz vs. Rubidium Evaluation) Trial · University of California, Los Angeles
Dec 2026Non-invasive Diagnosis of Coronary Microvascular Disease: Pilot Study · University of Leicester
Dec 2026Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patients With Heart Failure With Reduced Ejection Fraction Caused by Non-ischemic Etiology · Samsung Medical Center
Dec 2026Compound Danshen Dripping Pill for Diabetic Microvascular Angina · Qilu Hospital of Shandong University
Jan 2027Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic · University Hospital, Motol
Apr 2027Microvascular Coronary Rehabilitation For Improving Treatment - Feasibility Study · Royal United Hospitals Bath NHS Foundation Trust
Jun 2027Microvascular Angina Intervention With Compound Danshen Dripping Pill (MAIDS) · Qilu Hospital of Shandong University
Jul 2027Serial PET MPI in Patients Undergoing Cancer Treatment · University of California, Los Angeles

Who these studies take

Of the 27 Microvascular Angina studies recruiting now, 18 (67%) set no upper age limit and 3 (11%) stop at 75 or younger. 1 (4%) take children under 18. 1 (4%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 27
Age	Women	Men
10	0 (0%)	0 (0%)
18	21 (78%)	20 (74%)
30	24 (89%)	23 (85%)
40	26 (96%)	25 (93%)
50	27 (100%)	26 (96%)
65	27 (100%)	26 (96%)
75	27 (100%)	26 (96%)
85	22 (81%)	21 (78%)

Across all 111 studies, recruiting or not: 15% stop at 75 or younger and 4% at 65; 5% take children; 7% are for women only and 0% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Microvascular Angina studies take

Of 24 interventional studies with no phase under Microvascular Angina, half reached primary completion within 39 months of starting, counting those still running.

Start to primary completion	Every sponsor	Industry	Non-industry
Interventional, no phase	39 mo24–64 · 24 studies	—	—

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Coronary MicrovAscular Diseases Intervention With Compound Danshen Dropping PillsOct 21, 2026NCT07885462

Studies

Recruiting first, then most recently updated. Showing 50 of 111. Browse all 111 → or search them.